围术期给予盐酸艾司氯胺酮注射液对儿童术后急性疼痛影响的评价:一项前瞻性、多中心、随机、开放标签、平行组、实用性临床试验的研究方案
该研究为实用性随机对照试验,计划纳入3000例≤17岁手术患儿,按2:1随机接受盐酸艾司氯胺酮注射液或不含艾司氯胺酮的常规治疗。主要终点为术后48小时内FLACC(0-7岁)或NRS(8-17岁)评分的ROC曲线下面积及阿片类药物消耗量,旨在评估围术期艾司氯胺酮对儿童术后急性疼痛的效果。
要点
- 计划纳入3000例≤17岁手术患儿,2:1随机接受盐酸艾司氯胺酮注射液或常规治疗。
- 主要终点为术后48小时内FLACC/NRS评分的ROC曲线下面积及阿片类药物消耗量。
- 该试验为首个前瞻性评估儿童围术期艾司氯胺酮用于术后急性疼痛的实用性临床试验。
核心结论
- 该试验将是首个前瞻性评估围术期给予盐酸艾司氯胺酮注射液对儿童术后急性疼痛效果的实用性临床试验,对持续优化儿童临床麻醉与镇痛方案具有重要意义。
研究设计与样本
- 前瞻性、多中心、随机、开放标签、平行组、实用性临床试验。
- 计划纳入3000例≤17岁接受手术的儿童。
- 受试者按2:1随机接受盐酸艾司氯胺酮注射液或不含艾司氯胺酮的常规治疗,覆盖整个围术期。
主要发现
- 主要终点为术后48小时内FLACC(0-7岁)或NRS(8-17岁)评分的ROC曲线下面积,以及术后48小时内阿片类药物消耗量。
- 次要终点包括术后首次使用救援镇痛药的时间、术后48小时内救援镇痛率、麻醉苏醒时间、急诊谵妄发生率(0-7岁)、术后48小时焦虑抑郁量表评分变化(8-17岁)、术中不良事件发生率、术后不良事件发生率及药物经济学指标。
- 记录不良事件和严重不良事件以评估安全性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inadequate postoperative pain management increases the risk of adverse events after the surgery and aggressive perioperative pain prevention has both short-term and long-term benefits. S(+)-ketamine is an N-methyl-D-aspartic acid (NMDA) receptor antagonist with a strong analgesic effect and can significantly relieve postoperative acute pain and reduce opioid consumption. However, for children, it still needs to be confirmed by large sample clinical studies. METHODS: This is a pragmatic, randomized controlled trial which will evaluate the effect of perioperative administration of S(+)-ketamine hydrochloride injection for postoperative acute pain in children in a pragmatic clinical setting. A total of 3000 children (≤17 years old) undergoing surgery will be included in this protocol. Subjects will be randomized 2:1 to either receive S(+)-ketamine hydrochloride injection or conventional therapy without S(+)-ketamine during the entire perioperative period. The primary endpoints are the area under the receiver operating characteristic (ROC) curve of Face Legs Activity Cry and Consolability (FLACC, 0-7 years old) scale score or Numerical Rating Scale (NRS, 8-17 years old) score within 48 h after surgery, and the consumption of opioids within 48 h after surgery. The secondary endpoints include the time of first use of rescue analgesics after surgery, rescue analgesia rate within 48 h after surgery, anesthesia recovery time, incidence of emergency delirium (for 0-7 years old), changes of anxiety and depression scale scores at 48 h after surgery (for 8-17 years old), incidence of intraoperative adverse events (AEs), and incidence of postoperative AEs and pharmacoeconomic indicators. AEs and serious AEs were recorded to evaluate safety. DISCUSSION: This trial will be the first pragmatic clinical trial to prospectively assess the effect of perioperative administration of S(+)-ketamine hydrochloride injection for postoperative acute pain in children, which is of great significance to the continuous optimization of clinical anesthesia and analgesia programs for children. TRIAL REGISTRATION: This trial was registered in the U.S. National Institutes of Health ClinicalTrials.gov database ( http://clinicaltrials.gov ; Registration number: NCT04834427). Registered on 8 April 2021.
引用
- Wang H, Duan C, Zhang J, et al. Evaluation of the effect of perioperative administration of S(+)-ketamine hydrochloride injection for postoperative acute pain in children: study protocol for a prospective, multicenter, randomized, open-label, parallel-group, pragmatic clinical trial. Trials. 2022. PMID: 35870990. doi:10.1186/s13063-022-06534-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。